Mangoceuticals Inc. (MGRX)
2.49
-0.08 (-3.11%)
At close: Apr 21, 2025, 3:59 PM
2.45
-1.59%
Pre-market: Apr 22, 2025, 04:03 AM EDT
-3.11% (1D)
| Bid | 2.33 |
| Market Cap | 15.56M |
| Revenue (ttm) | 615.87K |
| Net Income (ttm) | -8.71M |
| EPS (ttm) | -4.84 |
| PE Ratio (ttm) | -0.51 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.62 |
| Volume | 180,346 |
| Avg. Volume (20D) | 174,373 |
| Open | 2.12 |
| Previous Close | 2.57 |
| Day's Range | 2.42 - 2.79 |
| 52-Week Range | 1.49 - 16.80 |
| Beta | 2.42 |
About MGRX
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc....
Sector Healthcare
IPO Date Mar 21, 2023
Employees 3
Stock Exchange NASDAQ
Ticker Symbol MGRX
Website https://www.mangorx.com
Just now
-3.11%
Shares of companies within the broader consumer st...
Unlock content with
Pro Subscription
1 week ago
-10.29%
Shares of companies within the broader consumer staples sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.
